Cemiplimab for kidney organ transplant recipients with advanced cutaneous squamous cell carcinoma: CONTRAC-1.

被引：0
|
作者：
Hanna, Glenn J.
Dharaneeswaran, Harita J.
Giobbie-Hurder, Anita
Harran, John J.
Liao, Zixi
Pai, Lori
Tchekmedyian, Vatche
Ruiz, Emily S.
Waldman, Abigail H.
Schmults, Chrysalyne D.
Lizotte, Patrick H.
Paweletz, Cloud P.
Riella, Leonardo V.
Murakami, Naoka
Silk, Ann W.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Tufts Med Ctr, Boston, MA USA
[3] Maine Med Ctr, Portland, ME USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Brigham & Womens Faulkner Hosp, Boston, MA USA
[6] Belfer Ctr Appl Canc Sci, Boston, MA USA
[7] DFCI PCC Fellowship Program Attendings, Boston, MA USA
[8] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9519
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cemiplimab-rwlc Approved in Advanced Cutaneous Squamous Cell Carcinoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (11) : 707 - 707
  • [22] Therapy with Cemiplimab for locally advanced cutaneous Squamous Cell Carcinoma (cSCC)
    Reschke, R.
    Simon, J. C.
    Kage, P.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 41 - 42
  • [23] Cemiplimab for advanced cutaneous squamous cell carcinoma: Real life experience
    Hober, C.
    Fredeau, L.
    Ledard, A. Pham
    Boubaya, M.
    Herms, F.
    Aubin, F.
    Benetton, N.
    Dinulescu, M.
    Jannic, A.
    Cesaire, L.
    Meyer, N.
    Modeste, A. B. Duval
    Archier, E.
    Lesage, C.
    Kramkimel, N.
    Arnault, J. P.
    Grange, F.
    Dalac, S.
    Mortier, L.
    Maubec, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S737 - S737
  • [24] The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients
    Zilberg, Catherine
    Lyons, James Guy
    Gupta, Ruta
    Ferguson, Angela
    Damian, Diona Lee
    ANNALS OF DERMATOLOGY, 2023, 35 (02) : 91 - 99
  • [25] Cutaneous microbial markers of squamous cell carcinoma risk in solid organ transplant recipients
    Ha, Megan V.
    Salem, Iman
    Al-Shakhshir, Hilmi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB38 - AB38
  • [26] Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients
    Blomberg, M.
    He, S. Y.
    Harwood, C.
    Arron, S. T.
    Demehri, S.
    Green, A.
    Asgari, M. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1225 - 1233
  • [27] Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients
    Genders, Roel E.
    Osinga, Joris A. J.
    Tromp, Elise E.
    O'Rourke, Peter
    Bouwes Bavinck, Jan N.
    Plasmeijer, Elsemieke I.
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (06) : 551 - 555
  • [28] Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Boutros, Andrea
    Croce, Elena
    Tanda, Enrica Teresa
    Cecchi, Federica
    Arecco, Luca
    Genova, Carlo
    Baldelli, Ilaria
    Lambertini, Matteo
    Raposio, Edoardo
    Del Mastro, Lucia
    Spagnolo, Francesco
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [29] Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
    Lanz, Joana
    Bavinck, Jan Nico Bouwes
    Westhuis, Marlies
    Quint, Koen D.
    Harwood, Catherine A.
    Nasir, Shaaira
    Van-de-Velde, Vanessa
    Proby, Charlotte M.
    Ferrandiz, Carlos
    Genders, Roel E.
    del Marmol, Veronique
    Forchetti, Giulia
    Hafner, Juerg
    Vital, Domenic G.
    Hofbauer, Guenther F. L.
    JAMA DERMATOLOGY, 2019, 155 (01) : 66 - 71
  • [30] Management of squamous cell carcinoma in organ transplant recipients
    Carucci, JA
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2003, 22 (03) : 177 - 186
12345